http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
TCA Chemical Peeling - 방법 , 부작용 및 242명의 환자가 평가한 치료효과 -
이정복(Jung Bock Lee),최현주(Hyun Joo Choi) 대한피부과학회 1993 대한피부과학회지 Vol.31 No.1
Tricholroacetic acid (TCA) chemical peeling is an effective, versatle and safe therapeutic method for patients with pigmentary disorders, acne scars and aging skin. With an experienced and skilled operator, the associated complications are rare and tend to be mild. No. ystemic toxicity is known to be induced by TCA. We observed the effect of TCA chemical peeling, evaluated by 242 patients themselves with melasma, freckles, senile lentgines, pigmented nevi, seborrheic keratosis, skin tags or acne scars. The patients evaluated TCA peeling as excellent for the treatment of seboirheic keratosis, pigmented nevi, skin tags and acne scars, and as selectively recommendable for the treatment of melasma, freckles and senile lentigines. (Kor J Dermatol 1903; 31 (1): 1-8)
조정희,강신복,김혜수,김영림,오미현,강인호,박성수,지선경,함일권,박만기 식품의약품안전청 1997 식품의약품안전청 연보 Vol.1 No.-
The raw materials of glycyrrhizin were examined for the preparation of korea Food Drug Administration(KFDA) reference standard. The candidate materials were evaluated by plchemical analysis : UV, FT-IR, water content, specific optical rotation, DSC, NMR, GC/MS, LC/MS, and HPLC. Based on the above results, the candidate materials were authorized as the glycyrrhiziu erence standard of KFDA. Also, standard anality of Glycyrrhizae Radix were examined by glycyi contents( % ), residual pesticides and heavy metal analysis. Glycyrrhizin contents of Glycyrrhizae Ran were 2.1~5.7% by HPLC analysis (column; u-Bondapak C_(18), mobile phase : diluted acetic acid(1→15) CH_(3)CN (3 : 2), detector : UV 254nm). The results of pesticide residue and heavy metat analysis passed for KFDA specification.
당뇨병환자에서 발생한 제V형 과지질단백혈증과 발진성 황색종
이정복,장진호,이상주,진상현 대한피부과학회 2000 대한피부과학회지 Vol.38 No.4
Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea We report a case of type V hyperlipoproteinemia and xanthoma eruptivum associated with diabetes mellitus in a 12-year-old female. She had diffuse erythematous yellowish papules on the extremities and trunk with itching. The laboratory findings showed increased serum blood glucose, cholesterol and triglyceride, increasing pre- and chylomicron bands on electrophoresis of lipoprotein. The biopsy specimen of an erythematous yellowish colored papule on the trunk showed characteristic findings of xanthoma.
Gemcitabine/cisplatin 항암치료 후 완전관해가 보고된 전이성 췌장암 환자 2례
조중현 ( Jung Hyun Jo ),정문재 ( Moon Jae Chung,),박정엽 ( Jeong Youp Park ),방승민 ( Seun Gmin Bang ),박승우 ( Seung Woo Park ),정재복 ( Jae Bock Chung ),송시영 ( Si Young Song ) 전북대학교 의과학연구소 2013 全北醫大論文集 Vol.37 No.1
Pancreatic ductal adenocarcinoma has a very poor prognosis. Patients with this type of tumor have a median overall survival of 9 months in locally advanced pancreatic cancer and 3-6 months in metastatic disease. However, there have been rare cases of patients with advanced pancreatic cancer who survived unexpectedly longer without curative surgery. We report two cases of metastatic pancreatic cancer in patients who presented complete remission after receiving gemcitabine/cisplatin chemotherapy and survived for about 10 years. The first case is that of a 51-year-old Korean woman who was diagnosed with pancreatic body cancer with invasion of the celiac artery and supraclavicular lymph node metastasis. The patient received gemcitabine/cisplatin systemic chemotherapy and achieved complete remission after the 12th cycle of chemotherapy. At present, the patient has survived for 10 years and 2 months after diagnosis. The second case is that of a 69-year-old Korean woman who was diagnosed with pancreatic head cancer with liver metastasis. The patient received gemcitabine/cisplatin chemotherapy and achieved complete remission after the 6th cycle of chemotherapy. At present, the patient has survived for 9 years and 2 months after diagnosis. Our study is the first case report of patients who achieved long-term survival with complete remission after receiving chemotherapy alone for metastatic pancreatic cancer.